Core Viewpoint - FOXO Technologies Inc. has received a notice from NYSE regarding the delisting of its Class A common stock due to the share price falling below the minimum requirement of $0.10, leading to immediate suspension of trading [1][2]. Company Actions - The company has applied for its common stock to be traded on the OTC market and received confirmation from FINRA that the trading symbol "FOXO" has been assigned for this purpose, effective August 13, 2025 [2]. - The CEO of FOXO expressed disappointment over the share price decline but reaffirmed the company's commitment to its business strategy and growth initiatives, including potential acquisitions [3]. Company Overview - FOXO operates three subsidiaries: - Rennova Community Health, Inc., which manages a critical access hospital in East Tennessee [4]. - Myrtle Recovery Centers, Inc., a behavioral health facility providing various treatment services [4]. - FOXO Labs, Inc., focused on biotechnology and health improvement through innovative technology [5].

WEST PALM BEACH, FLORIDA, Aug. 06, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”) announces that it has executed a non-binding acquisition agreement to acquire an assisted living and memory care facility in South Florida. The proposed acquisition includes the land and buildings. The facility has 87 units licensed for the provision of assisted living and memory care services. The purchase price for the facility is expected to be $22 million, a portion of which ...

Core Points - FOXO Technologies Inc. announced that Big South Fork Medical Center has completed a Performance Network Agreement with Covenant Health to provide swing bed services [1][3] - The agreement aims to enhance post-acute care for patients who no longer meet acute care admission criteria, allowing them to recover closer to home [2][3] - The CEO of Big South Fork Medical Center emphasized the hospital's strategic location and service quality as key factors in attracting patients [3] Company Overview - FOXO Technologies Inc. operates three subsidiaries, including Rennova Community Health, which owns Big South Fork Medical Center, a critical access designated hospital [4] - Myrtle Recovery Centers, another subsidiary, provides behavioral health services, including inpatient detox and outpatient treatment programs [4] - FOXO Labs, Inc. focuses on biotechnology aimed at improving human health and lifespan through innovative technology [5]

WEST PALM BEACH, FLORIDA, July 31, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies, Inc., (NYSE American: FOXO) (“FOXO” or the “Company”) today announced that its behavioral health subsidiary, Myrtle Recovery Centers, Inc., has renewed its operating license for its Oneida, TN location for another year. The license renewal to operate an alcohol and drug residential treatment facility was granted by the State of Tennessee’s Department of Mental Health and Substance Abuse Services after a successful annual inspecti ...

Core Viewpoint - FOXO Technologies Inc. has announced the spin-off of its subsidiary FOXO Labs, Inc., which focuses on epigenetics, aiming to enhance business strategy and shareholder value [1][3]. Group 1: Company Overview - FOXO Technologies operates three subsidiaries, including Rennova Community Health, Inc. and Myrtle Recovery Centers, Inc., which provide healthcare services [4]. - FOXO Labs, Inc. is dedicated to improving human health and lifespan through advanced technology and product solutions [5]. Group 2: Epigenetics Business - FOXO Labs is a pioneer in integrating epigenetic biomarkers into underwriting protocols and consumer engagement tools, holding Patent No. 11,817,214 for a machine learning model that uses DNA epigenetic data [1]. - The epigenetic technology developed by FOXO Labs offers insights into health, lifestyle, and longevity from a single saliva sample, eliminating the need for invasive testing [2]. Group 3: Business Strategy and Future Plans - The CEO of FOXO Labs emphasized that the spin-off will create opportunities for a subscription-based revenue model focused on personal health and longevity [3]. - The spin-off strategy allows FOXO shareholders to directly own FOXO Labs while retaining some ownership, simplifying the business model for both entities [3].

Core Insights - FOXO Technologies Inc. announced that its subsidiary Myrtle Recovery Centers has been approved for a second year of funding from Scott County Opioid Abatement Funds to provide care for uninsured patients starting July 1, 2025 [1][2] - Myrtle Recovery Centers operates at full capacity with a waiting list, indicating strong demand for its services and the quality of care provided [2] - FOXO Technologies plans to expand Myrtle Recovery Centers through organic growth and acquisitions, anticipating significant revenue contributions in the future [2] Company Overview - FOXO Technologies operates three subsidiaries: Rennova Community Health, which runs Scott County Community Hospital, Myrtle Recovery Centers, a 30-bed behavioral health facility, and FOXO Labs, a biotechnology company focused on health and lifespan improvement [3][4] - Myrtle Recovery Centers provides inpatient detox and residential treatment, as well as outpatient services for Medication-Assisted Treatment (MAT) and Office-Based Opioid Treatment (OBOT) programs [3]

Core Points - FOXO Technologies Inc. has designated a new series of preferred stock, Series E Cumulative Redeemable Secured Preferred Stock, with a stated value of $25.00 per share and a 2.5% cash dividend paid semi-annually [1] - The Series E Preferred Stock will serve as both an acquisition currency and a capital raising security, aimed at supporting the company's acquisition strategy and enhancing long-term value for stockholders [2] - FOXO operates three subsidiaries, including a critical access hospital and a behavioral health facility, indicating its involvement in the healthcare sector [3] Financial Details - The Series E Preferred Stock includes a 5.0% per annum common stock dividend paid semi-annually and a security interest in the stock of FOXO's acquisition vehicle [1] - The company intends to publicly list the Series E Preferred Stock with its own trading symbol at an appropriate time [2] Company Overview - FOXO Technologies Inc. focuses on improving human health and lifespan through biotechnology and innovative product solutions [4] - The company operates in the healthcare industry, with subsidiaries that provide critical access healthcare and behavioral health services [3]

Core Insights - FOXO Technologies Inc. has announced the launch of wound care services at its critical access hospital, Big South Fork Medical Center, in Oneida, Tennessee, to meet the growing demand, particularly among diabetic patients [1][2] Group 1: Company Overview - FOXO Technologies Inc. operates three subsidiaries, including Rennova Community Health, which manages the Big South Fork Medical Center [3] - The company also owns Myrtle Recovery Centers, a behavioral health facility providing various treatment services [3] Group 2: Service Expansion - The expansion of wound care services is expected to increase net revenues for the hospital and is part of a broader strategy to enhance market reach and service offerings [2]

Core Viewpoint - FOXO Technologies Inc. has established a new wholly-owned subsidiary, FOXO Acquisition Corporation, aimed at acquiring targets in the healthcare services sector, while also planning to create a new series of non-convertible preferred stock to facilitate these acquisitions [1][2]. Group 1: Company Developments - On June 13, 2025, FOXO formed FOXO Acquisition Corporation in Florida to pursue targeted acquisitions [2]. - The company plans to issue a new series of non-convertible preferred stock, which is expected to be publicly listed and will generate cash and common stock dividends for investors [2]. - CEO Seamus Lagan expressed optimism about the acquisition strategy, emphasizing non-dilutive funding for common stockholders and targeting acquisitions with significant growth potential [3]. Group 2: Leadership Changes - The company announced the passing of Interim Chief Financial Officer Martin Ward on June 9, 2025, and Seamus Lagan has been appointed as the Interim CFO while a search for a permanent replacement is underway [4]. Group 3: Company Overview - FOXO operates three subsidiaries: Rennova Community Health, which runs a critical access hospital in East Tennessee; Myrtle Recovery Centers, a behavioral health facility; and FOXO Labs, a biotechnology company focused on health and lifespan improvement [6][7].

Core Viewpoint - FOXO Technologies Inc. has executed an agreement to issue 1,650 shares of Series A Cumulative Convertible Redeemable Preferred Stock for net proceeds of $1,500,000, indicating a strategic move to enhance its financial position and support growth initiatives [1][2]. Financial Summary - The issuance of Series A Preferred Stock is expected to generate gross proceeds of $1,650,000, with the company agreeing to pay investor costs of $150,000 [2]. - The first closing of this transaction occurred on June 4, 2025, with subsequent closings planned based on the effective date of a registration statement [2]. - In the first quarter of 2025, FOXO reported over $3 million in net revenues and a $4.4 million improvement in stockholders' equity, bringing total stockholders' equity to $9.7 million as of March 31, 2025, compared to a negative $17.5 million as of September 30, 2024 [3]. Company Overview - FOXO Technologies operates three subsidiaries: Rennova Community Health, which runs a critical access hospital in East Tennessee; Myrtle Recovery Centers, a behavioral health facility; and FOXO Labs, a biotechnology company focused on health and lifespan improvement through innovative technology [4][5].